Tuberculosis immune reconstitution inflammatory syndrome in children initiating antiretroviral therapy for HIV infection: A systematic literature review

Pediatric Infectious Disease Journal

Volumn 33, Issue 5, 2014, Pages 499-503

  Link Gelles, Ruth ^a   Moultrie, Harry ^b   Sawry, Shobna ^b   Murdoch, David ^c   Van Rie, Annelies ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c DUKE UNIVERSITY   (United States)

Author keywords

antiretroviral treatment; immune reconstitution inflammatory syndrome; pediatric HIV AIDS; tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID;

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CHILDHOOD DISEASE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOGENESIS; INTESTINE PERFORATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; TUBERCULOSIS; TUBERCULOSIS ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; UPPER RESPIRATORY TRACT OBSTRUCTION; ADOLESCENT; AFRICA; ASIA; CHILD; COMPLICATION; HIV INFECTIONS; INCIDENCE; INFANT; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; RISK FACTOR; SOUTH AND CENTRAL AMERICA;

ADOLESCENT; AFRICA; ANTI-RETROVIRAL AGENTS; ASIA; CHILD; CHILD, PRESCHOOL; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INFANT; LATIN AMERICA; MORTALITY; RISK FACTORS; TUBERCULOSIS;

EID: 84899046368     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000142     Document Type: Article

References (51)

1. UNAIDS. UNAIDS report on the global AIDS epidemic. 2010. Available at: http://www.unaids.org/globalreport/Global-report.htm. Accessed January 9, 2013.
2. World Health Organization GS. Treatment of children living with HIV. 2013. Available at: http://www.who.int/hiv/topics/paediatric/en/index.html. Accessed January 9, 2013.
3. World Health Organization. Global summary of the AIDS epidemic. 2012. Available at: http://www.who.int/hiv/data/2012-epi-core-en.png. Accessed May 29, 2013.
4. Houben RM, Glynn JR, Mboma S, et al. The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting. AIDS. 2012;26:2233-2239.
5. Kouanda S, Meda IB, Nikiema L, et al. Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care. 2012;24:478-490.
6. Edmonds A, Yotebieng M, Lusiama J, et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med. 2011;8:e1001044.
7. Battegay M, Nüesch R, Hirschel B, et al. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis. 2006;6:280-287.
8. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000;1:107-115.
9. Stone SF, Price P, French MA. Immune restoration disease: a consequence of dysregulated immune responses after HAART. Curr HIV Res. 2004;2:235-242.
10. Meintjes G, Rabie H, Wilkinson RJ, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin Chest Med. 2009;30:797-810, x.
11. Murdoch DM, Venter WD, Van Rie A, et al. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther. 2007;4:9.
12. Calligaro G, Meintjes G, Mendelson M. Pulmonary manifestations of the immune reconstitution inflammatory syndrome. Curr Opin Pulm Med. 2011;17:180-188.
13. Price P, Murdoch DM, Agarwal U, et al. Immune restoration diseases reflect diverse immunopathological mechanisms. Clin Microbiol Rev. 2009;22:651-663.
14. Müller M, Wandel S, Colebunders R, et al.; IeDEA Southern and Central Africa. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:251-261.
15. Baalwa J, Mayanja-Kizza H, Kamya MR, et al. Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda. Afr Health Sci. 2008;8:190-195.
16. Haddow LJ, Moosa MY, Mosam A, et al. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS One. 2012;7:e40623.
17. Murdoch DM, Venter WD, Feldman C, et al. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008;22:601-610.
18. Pepper DJ, Marais S, Maartens G, et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis. 2009;48:e96-107.
19. Lawn SD, Myer L, Bekker LG, et al. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS. 2007;21:335-341.
20. Meintjes G, Wilkinson RJ, Morroni C, et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS. 2010;24:2381-2390.
21. Cohen JM, Whittaker E, Walters S, et al. Presentation, diagnosis and management of tuberculosis in HIV-infected children in the UK. HIV Med. 2008;9:277-284.
22. Edmonds A, Lusiama J, Napravnik S, et al. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children. Int J Epidemiol. 2009;38:1612-1621.
23. Severe P, Leger P, Charles M, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med. 2005;353:2325-2334.
24. Kilborn T, Zampoli M. Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children. Pediatr Radiol. 2009;39:569-574.
25. Zampoli M, Kilborn T, Eley B. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. Int J Tuberc Lung Dis. 2007;11:417-423.
26. Bakeera-Kitaka S, Conesa-Botella A, Dhabangi A, et al. Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis. 2011;15:1082-1086.
27. Smith K, Kuhn L, Coovadia A, et al. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS. 2009;23:1097-1107.
28. Walters E, Cotton MF, Rabie H, et al. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC pediatrics. 2008;8:1.
29. Wang ME, Castillo ME, Montano SM, et al. Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru. Pediatr Infect Dis J. 2009;28:900-903.
30. Yu JK, Bong CN, Chen SC, et al. Outcomes in HIV-infected patients who develop tuberculosis after starting antiretroviral treatment in Malawi. Int J Tuberc Lung Dis. 2008;12:692-694.
31. Okechukwu AA, Okechukwu OI. Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria. Niger J Clin Pract. 2011;14:206-211.
32. Shah I. Immune Reconstitution Syndrome in HIV-1 infected children-a study from India. Indian J Pediatr. 2011;78:540-543.
33. Puthanakit T, Oberdorfer P, Akarathum N, et al. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children. Pediatr Infect Dis J. 2006;25:53-58.
34. Orikiiriza J, Bakeera-Kitaka S, Musiime V, et al. The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children. AIDS. 2010;24:2009-2017.
35. Hayes E, Phiri A, Heikens T. Ward round in Moyo House: Management issues in malnourished children with HIV and tuberculosis (TB). Malawi Med J. 2009;21:120-122.
36. Narendran G, Swaminathan S, Sathish S, et al. Immune reconstitution syndrome in a child with TB and HIV. Indian J Pediatr. 2006;73:627-629.
37. Rabie H, Lomp A, Goussard P, et al. Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child. J Trop Pediatr. 2010;56:355-358.
38. Dunn D, Woodburn P, Duong T, et al.; HIV Paediatric Prognostic Markers Collaborative Study (HPPMCS); Concerted Action on Sero-Conversion to AIDS and Death in Europe (CASCADE) Collaboration. Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. J Infect Dis. 2008;197:398-404.
39. Luzuriaga K, McManus M, Catalina M, et al. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol. 2000;74:6984-6991.
40. Sandberg JK, Fast NM, Jordan KA, et al. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol. 2003;170:4403-4410.
41. Ziegner U, Campbell D, Weinhold K, et al. Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus ( HIV)-expressing target cells in perinatal HIV infection. Clin Diagn Lab Immunol. 1999;6:718-724.
42. Basu Roy R, Whittaker E, Kampmann B. Current understanding of the immune response to tuberculosis in children. Curr Opin Infect Dis. 2012;25:250-257.
43. Filias A, Theodorou GL, Mouzopoulou S, et al. Phagocytic ability of neutrophils and monocytes in neonates. BMC Pediatr. 2011;11:29.
44. Sepulveda RL, Arredondo S, Rodriguez E, et al. Effect of human newborn BCG immunization on monocyte viability and function at 3 months of age. Int J Tuberc Lung Dis. 1997;1:122-127.
45. Gold MC, Robinson TL, Cook MS, et al. Human neonatal dendritic cells are competent in MHC class I antigen processing and presentation. PLoS One. 2007;2:e957.
46. Upham JW, Rate A, Rowe J, et al. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect Immun. 2006;74:1106-1112.
47. Meintjes G, Lawn SD, Scano F, et al.; International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8:516-523.
48. Rabie H, Violari A, Duong T, et al.; CHER team. Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis. Int J Tuberc Lung Dis. 2011;15:1194-200, i.
49. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18:1615-1627.
50. International Network for the Study of HIVaI. TB-IRIS case definition. Available at: http://www.inshi.umn.edu/definitions/TB-IRIS/home.html. Accessed January 4, 2013.
51. Robertson J, Meier M, Wall J, et al. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006;42:1639-1646.